- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Aurobindo Pharma Limited — Important, 29-06-2025: General Updates
29-06-2025 | 04:41 pm
29-06-2025 | 04:41 pm
Aurobindo Pharma's wholly owned subsidiary, Lyfius Pharma, has resumed Penicillin-G production at its Kakinada facility after receiving the required environmental consent to operate. This restart enables the company to meet market demand for Penicillin-G and supports its API business continuity with no expected disruption.
No comments yet. Be the first to comment!